(The H4-Index of
Circulation is
540. The table below lists those papers that are above that threshold based on
CrossRef citation counts. The publications cover those that have been published in the past four years, i.e., from 2019-03-01 to 2023-03-01.)
Article | Citations |
---|
Heart Rate Variability | 9706 |
PhysioBank, PhysioToolkit, and PhysioNet | 7982 |
Prediction of Coronary Heart Disease Using Risk Factor Categories | 6216 |
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. | 5430 |
Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. | 5290 |
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association | 4694 |
Markers of Inflammation and Cardiovascular Disease | 4411 |
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines | 4083 |
Definition of Metabolic Syndrome | 3647 |
Impact of Atrial Fibrillation on the Risk of Death | 3197 |
Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. | 3112 |
Heart Disease and Stroke Statistics—2014 Update | 2964 |
Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. | 2620 |
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults | 2591 |
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease | 2485 |
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease | 2459 |
Derivation and Prospective Validation of a Simple Index for Prediction of Cardiac Risk of Major Noncardiac Surgery | 2452 |
Cardiovascular neural regulation explored in the frequency domain. | 2412 |
Coronary Plaque Disruption | 2338 |
A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Associati | 2231 |
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies | 2228 |
Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis | 2220 |
Atrial Fibrillation Begets Atrial Fibrillation | 2176 |
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. | 2107 |
The stunned myocardium: prolonged, postischemic ventricular dysfunction. | 2062 |
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk | 2045 |
Clinical Utility of Doppler Echocardiography and Tissue Doppler Imaging in the Estimation of Left Ventricular Filling Pressures | 2032 |
Mediterranean Diet, Traditional Risk Factors, and the Rate of Cardiovascular Complications After Myocardial Infarction | 1956 |
Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. | 1916 |
From Vulnerable Plaque to Vulnerable Patient | 1901 |
Cardiovascular Mortality and Long-Term Exposure to Particulate Air Pollution | 1825 |
Relationship of MRI Delayed Contrast Enhancement to Irreversible Injury, Infarct Age, and Contractile Function | 1777 |
Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse Long-Term Outcome of Coronary Heart Disease | 1753 |
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis | 1733 |
Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. | 1708 |
Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. | 1701 |
Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal Cells | 1683 |
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events | 1669 |
Impact of Psychological Factors on the Pathogenesis of Cardiovascular Disease and Implications for Therapy | 1668 |
Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention | 1647 |
Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI) | 1646 |
Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome | 1607 |
Air Pollution and Cardiovascular Disease | 1571 |
Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises | 1567 |
Novel Modulator for Endothelial Adhesion Molecules | 1552 |
Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans | 1545 |
Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. | 1530 |
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals | 1527 |
Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men | 1522 |
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults | 1521 |
Hemodynamic Patterns of Age-Related Changes in Blood Pressure | 1460 |
The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. | 1451 |
Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four con | 1450 |
Common Carotid Intima-Media Thickness and Risk of Stroke and Myocardial Infarction | 1449 |
Lifetime Risk for Development of Atrial Fibrillation | 1435 |
Impact of Aortic Stiffness on Survival in End-Stage Renal Disease | 1421 |
Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality | 1360 |
Long-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial Dysfunction | 1336 |
Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans | 1330 |
Exercise and Physical Activity in the Prevention and Treatment of Atherosclerotic Cardiovascular Disease | 1330 |
ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary | 1323 |
Peripheral Blood “Endothelial Progenitor Cells” Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth Factors | 1321 |
Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults | 1316 |
Diabetes and Cardiovascular Disease | 1313 |
Human Epicardial Adipose Tissue Is a Source of Inflammatory Mediators | 1306 |
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Tas | 1305 |
Brugada Syndrome: Report of the Second Consensus Conference | 1303 |
Total Excitation of the Isolated Human Heart | 1302 |
Prevalence of and Risk Factors for Peripheral Arterial Disease in the United States | 1302 |
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease | 1293 |
Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. | 1280 |
C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men | 1276 |
Transluminal Treatment of Arteriosclerotic Obstruction | 1275 |
Genotype-Phenotype Correlation in the Long-QT Syndrome | 1269 |
Atherogenesis: a postprandial phenomenon. | 1267 |
AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update | 1266 |
Sudden Cardiac Death | 1260 |
Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults | 1254 |
Molecular Bases of the Acute Coronary Syndromes | 1249 |
Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF-κB Signaling Through a cAMP-Dependent Pathway | 1245 |
Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. | 1236 |
Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors | 1224 |
Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention | 1212 |
Impact of Reduced Heart Rate Variability on Risk for Cardiac Events | 1211 |
Factors Influencing Infarct Size Following Experimental Coronary Artery Occlusions | 1199 |
TIMI Frame Count | 1199 |
Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction | 1195 |
Mechanism of Action of Fibrates on Lipid and Lipoprotein Metabolism | 1191 |
Survival after the onset of congestive heart failure in Framingham Heart Study subjects. | 1191 |
Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. | 1190 |
Left Ventricular Remodeling After Myocardial Infarction | 1188 |
Clopidogrel for Coronary Stenting | 1186 |
Quantification of Myocardial Blood Flow With Ultrasound-Induced Destruction of Microbubbles Administered as a Constant Venous Infusion | 1178 |
Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. | 1170 |
Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells | 1168 |
Comparison of the Short-Term Survival Benefit Associated With Revascularization Compared With Medical Therapy in Patients With No Prior Coronary Artery Disease Undergoing Stress Myocardial Perfusion S | 1163 |
Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent | 1151 |
Aortic Pulse-Wave Velocity and Its Relationship to Mortality in Diabetes and Glucose Intolerance | 1149 |
An updated coronary risk profile. A statement for health professionals. | 1147 |
Right ventricular dysplasia: a report of 24 adult cases. | 1147 |
Cardiac Arrest and Cardiopulmonary Resuscitation Outcome Reports | 1146 |
Stroke Prevention in Atrial Fibrillation Study. Final results. | 1136 |
Is Pulse Pressure Useful in Predicting Risk for Coronary Heart Disease? | 1135 |
Atherosclerosis: Basic Mechanisms | 1132 |
Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular Structures | 1132 |
AHA Dietary Guidelines | 1127 |
Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population | 1123 |
Lifetime Risk for Developing Congestive Heart Failure | 1117 |
Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-α, in Patients With Moderate-to-Severe Heart Failure | 1108 |
Frequency domain measures of heart period variability and mortality after myocardial infarction. | 1100 |
Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation | 1098 |
Nitric Oxide Is Responsible for Flow-Dependent Dilatation of Human Peripheral Conduit Arteries In Vivo | 1096 |
Executive Summary: Heart Disease and Stroke Statistics—2014 Update | 1095 |
Socioeconomic factors and cardiovascular disease: a review of the literature. | 1091 |
Canadian Implantable Defibrillator Study (CIDS) | 1080 |
Plasticity of Human Adipose Lineage Cells Toward Endothelial Cells | 1075 |
Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study | 1072 |
HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. | 1057 |
Depression and 18-Month Prognosis After Myocardial Infarction | 1055 |
Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy Women | 1038 |
Prognostic Value of Coronary Vascular Endothelial Dysfunction | 1032 |
Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? | 1032 |
Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the Utstein Style. A statement for health professionals from a task force of the American Heart Association, t | 1030 |
Ischemic Mitral Regurgitation | 1024 |
Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial Infarction | 1021 |
Role of Endothelial Dysfunction in Atherosclerosis | 1007 |
Promotion of Atrial Fibrillation by Heart Failure in Dogs | 1003 |
Time Delay to Treatment and Mortality in Primary Angioplasty for Acute Myocardial Infarction | 998 |
Human blood pressure determination by sphygmomanometry. | 997 |
Inflammation as a Risk Factor for Atrial Fibrillation | 992 |
Local Delivery of Marrow-Derived Stromal Cells Augments Collateral Perfusion Through Paracrine Mechanisms | 990 |
The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. | 987 |
Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). | 987 |
Intracoronary Stenting Without Anticoagulation Accomplished With Intravascular Ultrasound Guidance | 986 |
Prognostic Significance of Microvascular Obstruction by Magnetic Resonance Imaging in Patients With Acute Myocardial Infarction | 986 |
Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. | 985 |
Current Concepts of the Pathogenesis of the Acute Coronary Syndromes | 982 |
Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. | 979 |
Color Doppler assessment of mitral regurgitation with orthogonal planes. | 978 |
TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation | 977 |
Imaging Atherosclerotic Plaque Inflammation With [
18
F]-Fluorodeoxyglucose Positron Emission Tomography | 976 |
Coronary Artery Calcium Area by Electron-Beam Computed Tomography and Coronary Atherosclerotic Plaque Area | 975 |
Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Grou | 971 |
Overweight in Children and Adolescents | 970 |
Initiation of Atrial Fibrillation by Ectopic Beats Originating From the Pulmonary Veins | 970 |
Increased Particulate Air Pollution and the Triggering of Myocardial Infarction | 969 |
Randomized Comparison of Antiarrhythmic Drug Therapy With Implantable Defibrillators in Patients Resuscitated From Cardiac Arrest | 969 |
The Pathology of Hypertensive Pulmonary Vascular Disease | 965 |
Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction | 953 |
Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart Failure | 952 |
The Epidemiology of Venous Thromboembolism | 950 |
Circadian variation and triggers of onset of acute cardiovascular disease. | 946 |
Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein | 946 |
Improving survival from sudden cardiac arrest: the "chain of survival" concept. A statement for health professionals from the Advanced Cardiac Life Support Subcommittee and the Emergency Cardiac Care | 946 |
Nonpenetrating Traumatic Injury of the Aorta | 942 |
Estimation of Central Aortic Pressure Waveform by Mathematical Transformation of Radial Tonometry Pressure | 942 |
Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. | 941 |
Morning Surge in Blood Pressure as a Predictor of Silent and Clinical Cerebrovascular Disease in Elderly Hypertensives | 938 |
Secondary Prevention by Raising HDL Cholesterol and Reducing Triglycerides in Patients With Coronary Artery Disease | 937 |
Relation Between Folate Status, a Common Mutation in Methylenetetrahydrofolate Reductase, and Plasma Homocysteine Concentrations | 935 |
Mutations in the Cardiac Ryanodine Receptor Gene (
hRyR2
) Underlie Catecholaminergic Polymorphic Ventricular Tachycardia | 932 |
Metabolic Syndrome | 930 |
Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. | 929 |
Circumferential Radiofrequency Ablation of Pulmonary Vein Ostia | 929 |
An overview of randomized trials of rehabilitation with exercise after myocardial infarction. | 924 |
Long-term Consequences of Kawasaki Disease | 924 |
Characterization of Human Atherosclerosis by Optical Coherence Tomography | 924 |
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. | 924 |
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. | 923 |
Isolated noncompaction of left ventricular myocardium. A study of eight cases. | 922 |
Angiographic Assessment of Myocardial Reperfusion in Patients Treated With Primary Angioplasty for Acute Myocardial Infarction | 922 |
Approaches to Sudden Death from Coronary Heart Disease | 916 |
Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data. | 916 |
Histological Substrate of Atrial Biopsies in Patients With Lone Atrial Fibrillation | 916 |
Incidence of and Risk Factors for Atrial Fibrillation in Older Adults | 916 |
Systemic Delivery of Bone Marrow–Derived Mesenchymal Stem Cells to the Infarcted Myocardium | 915 |
Angiographic Patterns of In-Stent Restenosis | 914 |
Differentiation of Human Embryonic Stem Cells to Cardiomyocytes | 904 |
Systolic Time Intervals in Heart Failure in Man | 901 |
Diabetes and Vascular Disease | 899 |
Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. | 899 |
Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages | 898 |
Carvedilol Produces Dose-Related Improvements in Left Ventricular Function and Survival in Subjects With Chronic Heart Failure | 897 |
Coronary Plaque Classification With Intravascular Ultrasound Radiofrequency Data Analysis | 896 |
2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk | 891 |
Hypertrophic Cardiomyopathy | 890 |
State of Disparities in Cardiovascular Health in the United States | 888 |
Circulating Adhesion Molecules VCAM-1, ICAM-1, and E-selectin in Carotid Atherosclerosis and Incident Coronary Heart Disease Cases | 888 |
Stromal Cell–Derived Factor-1 Effects on Ex Vivo Expanded Endothelial Progenitor Cell Recruitment for Ischemic Neovascularization | 885 |
Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. | 883 |
Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure | 883 |
Unstable angina. A classification. | 875 |
High-Sensitivity C-Reactive Protein | 873 |
Effect of Cardiac Resynchronization Therapy on Left Ventricular Size and Function in Chronic Heart Failure | 871 |
Targeted Anticytokine Therapy in Patients With Chronic Heart Failure | 871 |
Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol Levels | 861 |
Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia | 857 |
Use of signals in the terminal QRS complex to identify patients with ventricular tachycardia after myocardial infarction. | 856 |
Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study | 856 |
Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises | 855 |
Cardiovascular Morbidity and Mortality in Women Diagnosed With Rheumatoid Arthritis | 855 |
Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium-Enhanced Cardiovascular Magnetic Resonance | 853 |
High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. | 852 |
Patterns and Mechanisms of In-Stent Restenosis | 852 |
Current Perspectives on Statins | 850 |
Incremental Prognostic Value of Myocardial Perfusion Single Photon Emission Computed Tomography for the Prediction of Cardiac Death | 849 |
Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in to | 846 |
Spectrum of Mutations in Long-QT Syndrome Genes | 846 |
Does the Relation of Blood Pressure to Coronary Heart Disease Risk Change With Aging? | 841 |
From Vulnerable Plaque to Vulnerable Patient | 838 |
ACC/AHA 2002 Guideline Update for Exercise Testing: Summary Article | 834 |
Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. | 829 |
The Electrocardiogram in Population Studies | 826 |
Current Perspectives on Arterial Stiffness and Pulse Pressure in Hypertension and Cardiovascular Diseases | 825 |
Diabetes and cardiovascular risk factors: the Framingham study. | 823 |
Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. | 823 |
Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. | 823 |
Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia | 822 |
Measurement of Coronary Sinus Blood Flow by Continuous Thermodilution in Man | 821 |
Congenital Heart Disease in 56,109 Births Incidence and Natural History | 820 |
Coronary Plaque Erosion Without Rupture Into a Lipid Core | 820 |
Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. | 810 |
Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal | 810 |
Endothelial Function | 807 |
Survival in Primary Pulmonary Hypertension | 805 |
Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction | 804 |
Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure | 802 |
An Accurate, Clinically Practical System For Spatial Vectorcardiography | 800 |
Effect of Pacing Chamber and Atrioventricular Delay on Acute Systolic Function of Paced Patients With Congestive Heart Failure | 800 |
Progression From Compensated Hypertrophy to Failure in the Pressure-Overloaded Human Heart | 797 |
The VIVA Trial | 796 |
Cardiac troponin I. A marker with high specificity for cardiac injury. | 795 |
Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events | 795 |
Myocardial Strain by Doppler Echocardiography | 792 |
Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice | 788 |
Cardiovascular Magnetic Resonance Assessment of Human Myocarditis | 787 |
Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure | 785 |
Nifedipine | 783 |
Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. | 783 |
Circadian variation in the frequency of sudden cardiac death. | 783 |
Catheter Technique for Recording His Bundle Activity in Man | 779 |
Sleep Apnea in 81 Ambulatory Male Patients With Stable Heart Failure | 778 |
Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery Lesions | 775 |
Cellular Basis for the Brugada Syndrome and Other Mechanisms of Arrhythmogenesis Associated With ST-Segment Elevation | 772 |
Arterial Stiffness, Wave Reflections, and the Risk of Coronary Artery Disease | 772 |
Linear Ablation Lesions for Control of Unmappable Ventricular Tachycardia in Patients With Ischemic and Nonischemic Cardiomyopathy | 772 |
Development and Prospective Validation of a Clinical Index to Predict Survival in Ambulatory Patients Referred for Cardiac Transplant Evaluation | 771 |
Constitutive Expression of phVEGF
165
After Intramuscular Gene Transfer Promotes Collateral Vessel Development in Patients With Critical Limb Ischemia | 768 |
Small, Dense Low-Density Lipoprotein Particles as a Predictor of the Risk of Ischemic Heart Disease in Men | 768 |
Our Preoccupation With Coronary Luminology | 767 |
Noninvasive determination of age-related changes in the human arterial pulse. | 766 |
Some Aspects of the Biological Role of Adenosine 3',5'-monophosphate (Cyclic AMP) | 764 |
Association of Atrial Fibrillation and Obstructive Sleep Apnea | 764 |
Postoperative Course and Hemodynamic Profile After the Arterial Switch Operation in Neonates and Infants | 761 |
Aging, Habitual Exercise, and Dynamic Arterial Compliance | 757 |
Pulmonary Vein Denervation Enhances Long-Term Benefit After Circumferential Ablation for Paroxysmal Atrial Fibrillation | 754 |
Sympathovagal Balance | 751 |
Predictors of Atrial Fibrillation After Coronary Artery Surgery | 751 |
Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt. | 750 |
Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. | 748 |
Aortocoronary Saphenous Vein Graft Disease | 746 |
Diagnostic criteria for the long QT syndrome. An update. | 744 |
Prognostic Value of Ambulatory and Home Blood Pressures Compared With Office Blood Pressure in the General Population | 740 |
The prevalence of peripheral arterial disease in a defined population. | 739 |
Left Atrial Size and the Risk of Stroke and Death | 739 |
Randomized, Controlled Trial of Long-Term Moderate Exercise Training in Chronic Heart Failure | 739 |
Monitoring of Bone Marrow Cell Homing Into the Infarcted Human Myocardium | 739 |
Prospective Study of Asymptomatic Valvular Aortic Stenosis | 739 |
Endothelial Cell Senescence in Human Atherosclerosis | 738 |
Acute and Reversible Cardiomyopathy Provoked by Stress in Women From the United States | 738 |
Renal Function, Neurohormonal Activation, and Survival in Patients With Chronic Heart Failure | 737 |
Physiological Analysis of Middle-Aged and Old Former Athletes | 733 |
Mechanisms of Increased Vascular Superoxide Production in Human Diabetes Mellitus | 730 |
Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2 | 730 |
Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. | 729 |
Effects of age and aerobic capacity on arterial stiffness in healthy adults. | 725 |
A Self-Fulfilling Prophecy | 725 |
Statin Therapy Accelerates Reendothelialization | 723 |
Coronary Artery Calcification: Pathophysiology, Epidemiology, Imaging Methods, and Clinical Implications | 722 |
Impact of Obesity on Plasma Natriuretic Peptide Levels | 721 |
Aortic input impedance in normal man: relationship to pressure wave forms. | 720 |
Cardiovascular Magnetic Resonance in Cardiac Amyloidosis | 720 |
Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes | 719 |
A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. | 719 |
Exercise and Heart Failure | 714 |
Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. | 713 |
Primary pulmonary hypertension: natural history and the importance of thrombosis. | 713 |
Clinical Implications of the ‘No Reflow’ Phenomenon | 713 |
Reliable Noninvasive Coronary Angiography With Fast Submillimeter Multislice Spiral Computed Tomography | 712 |
Prognostic Significance of Endothelial Dysfunction in Hypertensive Patients | 712 |
Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease. | 712 |
Cytokines and Cytokine Receptors in Advanced Heart Failure | 711 |
Effect of Medical Treatment in Stroke Patients With Patent Foramen Ovale | 710 |
Combined Ventricular Systolic and Arterial Stiffening in Patients With Heart Failure and Preserved Ejection Fraction | 710 |
Insights Into Causal Pathways for Ischemic Heart Disease | 706 |
Prevalence of the Metabolic Syndrome in American Adolescents | 706 |
Detection of Coronary Artery Stenoses With Thin-Slice Multi-Detector Row Spiral Computed Tomography and Multiplanar Reconstruction | 705 |
β-Adrenergic Receptor Blockade in Chronic Heart Failure | 704 |
Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial Infarction | 704 |
Supravalvular Aortic Stenosis | 703 |
A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees. | 702 |
Successful Cardiopulmonary Resuscitation After Cardiac Arrest as a “Sepsis-Like” Syndrome | 701 |
Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. | 700 |
Congestive Heart Failure in the Community | 700 |
Continuous measurement of left ventricular volume in animals and humans by conductance catheter. | 700 |
Cellular Basis for the Normal T Wave and the Electrocardiographic Manifestations of the Long-QT Syndrome | 698 |
Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. | 698 |
Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. | 697 |
In Vivo Characterization of Coronary Atherosclerotic Plaque by Use of Optical Coherence Tomography | 697 |
Vasopressin Deficiency Contributes to the Vasodilation of Septic Shock | 696 |
Double-Blind Study of the Safety of Clopidogrel With and Without a Loading Dose in Combination With Aspirin Compared With Ticlopidine in Combination With Aspirin After Coronary Stenting | 695 |
Improvement of Postnatal Neovascularization by Human Adipose Tissue-Derived Stem Cells | 692 |
Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia. | 691 |
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. | 691 |
Catheter Ablation for Paroxysmal Atrial Fibrillation | 690 |
Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombol | 689 |
Pravastatin Treatment Increases Collagen Content and Decreases Lipid Content, Inflammation, Metalloproteinases, and Cell Death in Human Carotid Plaques | 689 |
Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. | 689 |
Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris. | 687 |
Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work. | 686 |
Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. | 685 |
Atrio-Esophageal Fistula as a Complication of Percutaneous Transcatheter Ablation of Atrial Fibrillation | 685 |
Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises | 684 |
Effects of Glucagon-Like Peptide-1 in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction After Successful Reperfusion | 684 |
Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. | 683 |
Predictors of 30-Day Mortality in the Era of Reperfusion for Acute Myocardial Infarction | 683 |
Left Ventricular Hypertrophy | 681 |
Report of the American Society of Echocardiography Committee on Nomenclature and Standards in Two-dimensional Echocardiography. | 679 |
Attenuation of Compensation of Endogenous Cardiac Natriuretic Peptide System in Chronic Heart Failure | 679 |
Impact of Aortic Stiffness Attenuation on Survival of Patients in End-Stage Renal Failure | 678 |
Gene Therapy for Myocardial Angiogenesis | 678 |
Mechanism of myocardial "stunning". | 677 |
Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. | 677 |
Relationship of High and Low Ankle Brachial Index to All-Cause and Cardiovascular Disease Mortality | 677 |
Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. | 675 |
Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart | 675 |
Frequency by Decades of Unicuspid, Bicuspid, and Tricuspid Aortic Valves in Adults Having Isolated Aortic Valve Replacement for Aortic Stenosis, With or Without Associated Aortic Regurgitation | 675 |
Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. | 674 |
A Focal Source of Atrial Fibrillation Treated by Discrete Radiofrequency Ablation | 674 |
Randomized, Placebo-Controlled Trial of Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients | 673 |
Cardiovascular Events and Their Reduction With Pravastatin in Diabetic and Glucose-Intolerant Myocardial Infarction Survivors With Average Cholesterol Levels | 672 |
Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. | 671 |
Inflammatory Markers and Onset of Cardiovascular Events | 671 |
Cardiac Rehabilitation and Secondary Prevention of Coronary Heart Disease | 671 |
Why Are Patients With Chronic Obstructive Pulmonary Disease at Increased Risk of Cardiovascular Diseases? | 669 |
Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations | 669 |
Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. | 667 |
The long QT syndrome. Prospective longitudinal study of 328 families. | 665 |
Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community. | 664 |
Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure | 664 |
Angiotensin-Converting Enzyme Inhibition With Quinapril Improves Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease | 663 |
Obstructive Sleep Apnea and the Recurrence of Atrial Fibrillation | 662 |
Effect of Rosiglitazone Treatment on Nontraditional Markers of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus | 660 |
Diagnosis and Treatment of Fetal Cardiac Disease | 659 |
Bone Formation and Inflammation in Cardiac Valves | 658 |
Simvastatin, an HMG–Coenzyme A Reductase Inhibitor, Improves Endothelial Function Within 1 Month | 657 |
Birth Weight and Adult Hypertension, Diabetes Mellitus, and Obesity in US Men | 657 |
Superoxide Production and Expression of Nox Family Proteins in Human Atherosclerosis | 656 |
Oxidative Stress and Cardiovascular Injury | 655 |
Galectin-3 Marks Activated Macrophages in Failure-Prone Hypertrophied Hearts and Contributes to Cardiac Dysfunction | 655 |
Elevated Levels of C-Reactive Protein and Interleukin-6 in Patients With Obstructive Sleep Apnea Syndrome Are Decreased by Nasal Continuous Positive Airway Pressure | 654 |
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Summary Article | 654 |
Effects of adenosine on human coronary arterial circulation. | 652 |
Improved Left Ventricular Mechanics From Acute VDD Pacing in Patients With Dilated Cardiomyopathy and Ventricular Conduction Delay | 652 |
Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure. | 651 |
Detection of Calcified and Noncalcified Coronary Atherosclerotic Plaque by Contrast-Enhanced, Submillimeter Multidetector Spiral Computed Tomography | 648 |
Prognostic Value of Troponin I in Cardiac Risk Stratification of Cancer Patients Undergoing High-Dose Chemotherapy | 647 |
TAXUS I | 647 |
High-density mapping of electrically induced atrial fibrillation in humans. | 646 |
Hypertriglyceridemic Waist | 646 |
Clinical Implications of Obesity With Specific Focus on Cardiovascular Disease | 645 |
B-Type Natriuretic Peptide and Clinical Judgment in Emergency Diagnosis of Heart Failure | 645 |
Chronic Rapid Atrial Pacing | 644 |
Effects of Platelet Glycoprotein IIb/IIIa Blockade With Tirofiban on Adverse Cardiac Events in Patients With Unstable Angina or Acute Myocardial Infarction Undergoing Coronary Angioplasty | 641 |
Elevated C-Reactive Protein in Patients With Obstructive Sleep Apnea | 640 |
Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT) | 639 |
Stromal Cell–Derived Factor-1α Plays a Critical Role in Stem Cell Recruitment to the Heart After Myocardial Infarction but Is Not Sufficient to Induce Homing in the Absence of Injury | 638 |
Resistin Is an Inflammatory Marker of Atherosclerosis in Humans | 637 |
Catecholaminergic Polymorphic Ventricular Tachycardia in Children | 637 |
Diagnosis and Treatment of Chronic Arterial Insufficiency of the Lower Extremities: A Critical Review | 637 |
Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function. | 635 |
Emerging Epidemic of Cardiovascular Disease in Developing Countries | 634 |
Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques Can Be Detected by In Vivo Magnetic Resonance Imaging | 634 |
Regular Physical Activity Improves Endothelial Function in Patients With Coronary Artery Disease by Increasing Phosphorylation of Endothelial Nitric Oxide Synthase | 634 |
Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart Failure | 631 |
Hypertrophy of the Heart | 629 |
Electrophysiological Breakthroughs From the Left Atrium to the Pulmonary Veins | 629 |
Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure | 629 |
C-Reactive Protein Adds to the Predictive Value of Total and HDL Cholesterol in Determining Risk of First Myocardial Infarction | 625 |
Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. | 625 |
Safety of transesophageal echocardiography. A multicenter survey of 10,419 examinations. | 625 |
Bidirectional Relation Between Inflammation and Coagulation | 623 |
Interobserver variability in coronary angiography. | 621 |
Regular Physical Exercise Corrects Endothelial Dysfunction and Improves Exercise Capacity in Patients With Chronic Heart Failure | 621 |
Plasma Concentration of C-Reactive Protein and Risk of Developing Peripheral Vascular Disease | 620 |
Aneurysmal coronary artery disease. | 620 |
Elevation of Tumor Necrosis Factor-α and Increased Risk of Recurrent Coronary Events After Myocardial Infarction | 620 |
Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. | 620 |
Mechanism Linking T-Wave Alternans to the Genesis of Cardiac Fibrillation | 619 |
Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiova | 619 |
Complete Isolation of Left Atrium Surrounding the Pulmonary Veins | 618 |
Clinical Management of Metabolic Syndrome | 617 |
Thoracic and Abdominal Aortic Aneurysms | 615 |
The Athlete’s Heart | 615 |
Marked Inflammatory Sequelae to Implantation of Biodegradable and Nonbiodegradable Polymers in Porcine Coronary Arteries | 615 |
Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome | 615 |
Explaining How “High-Grade” Systemic Inflammation Accelerates Vascular Risk in Rheumatoid Arthritis | 614 |
Effect of Nasal Continuous Positive Airway Pressure Treatment on Blood Pressure in Patients With Obstructive Sleep Apnea | 614 |
Pravastatin and the Development of Diabetes Mellitus | 614 |
Short-Term Heart Rate Variability Strongly Predicts Sudden Cardiac Death in Chronic Heart Failure Patients | 613 |
Essential Hypertension | 612 |
Randomized Study to Evaluate Sirolimus-Eluting Stents Implanted at Coronary Bifurcation Lesions | 612 |
Hyperventilation-Induced Hypotension During Cardiopulmonary Resuscitation | 611 |
Risk Factors for Venous Thromboembolism | 610 |
Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. | 610 |
Akt Promotes Survival of Cardiomyocytes In Vitro and Protects Against Ischemia-Reperfusion Injury in Mouse Heart | 610 |
Platelet aggregation in partially obstructed vessels and its elimination with aspirin. | 609 |
Identification of Patients at Increased Risk of First Unheralded Acute Myocardial Infarction by Electron-Beam Computed Tomography | 609 |
Stent Thrombosis in the Modern Era | 609 |
Sudden Death Associated With Short-QT Syndrome Linked to Mutations in HERG | 609 |
Mesenchymal Stem Cells Differentiate into an Endothelial Phenotype, Enhance Vascular Density, and Improve Heart Function in a Canine Chronic Ischemia Model | 607 |
Risk Stratification for Postoperative Cardiovascular Events via Noninvasive Assessment of Endothelial Function | 605 |
Electrophysiological End Point for Catheter Ablation of Atrial Fibrillation Initiated From Multiple Pulmonary Venous Foci | 603 |
Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. | 603 |
Guide to the Assessment of Physical Activity: Clinical and Research Applications | 603 |
Coronary Anomalies | 602 |
Pathology of Acute and Chronic Coronary Stenting in Humans | 602 |
Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes | 602 |
Pulsed Doppler echocardiographic determination of stroke volume and cardiac output: clinical validation of two new methods using the apical window. | 601 |
Arrhythmogenic Right Ventricular Cardiomyopathy | 600 |
Regular Aerobic Exercise Prevents and Restores Age-Related Declines in Endothelium-Dependent Vasodilation in Healthy Men | 600 |
Relationship of TIMI Myocardial Perfusion Grade to Mortality After Administration of Thrombolytic Drugs | 600 |
Impact of Diabetes on Cardiac Structure and Function | 600 |
Predictors of Outcome in Patients With Acute Coronary Syndromes Without Persistent ST-Segment Elevation | 600 |
Microalbuminuria Reduction With Valsartan in Patients With Type 2 Diabetes Mellitus | 598 |
Physical Training Increases Endothelial Progenitor Cells, Inhibits Neointima Formation, and Enhances Angiogenesis | 598 |
Recovered Pulmonary Vein Conduction as a Dominant Factor for Recurrent Atrial Tachyarrhythmias After Complete Circular Isolation of the Pulmonary Veins | 598 |
Elevated Levels of Shed Membrane Microparticles With Procoagulant Potential in the Peripheral Circulating Blood of Patients With Acute Coronary Syndromes | 597 |
Ambient Pollution and Heart Rate Variability | 595 |
One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS Stent | 595 |
Prospective Randomized Multicenter Trial of Empirical Antitachycardia Pacing Versus Shocks for Spontaneous Rapid Ventricular Tachycardia in Patients With Implantable Cardioverter-Defibrillators | 594 |
Case Definitions for Acute Coronary Heart Disease in Epidemiology and Clinical Research Studies | 594 |
Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of cli | 593 |
Initial and 6-Month Results of Biodegradable Poly-
l
-Lactic Acid Coronary Stents in Humans | 593 |
Fractional Flow Reserve | 593 |
Electron-Beam Tomography Coronary Artery Calcium and Cardiac Events | 593 |
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines | 592 |
Classification of Human Carotid Atherosclerotic Lesions With In Vivo Multicontrast Magnetic Resonance Imaging | 591 |
Lipoprotein(a) and Coronary Heart Disease | 590 |
Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. | 590 |
Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction | 590 |
Proposed Diagnostic Criteria for the Brugada Syndrome | 587 |
Relationship Between Spectral Components of Cardiovascular Variabilities and Direct Measures of Muscle Sympathetic Nerve Activity in Humans | 586 |
Stability and Instability: Two Faces of Coronary Atherosclerosis | 585 |
Risk of Worsening Renal Function With Nesiritide in Patients With Acutely Decompensated Heart Failure | 585 |
Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. | 585 |
Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Proje | 585 |
The problem of valve prosthesis-patient mismatch. | 584 |
Quantitative coronary arteriography: estimation of dimensions, hemodynamic resistance, and atheroma mass of coronary artery lesions using the arteriogram and digital computation. | 584 |
C-Reactive Protein as a Cardiovascular Risk Factor | 583 |
Exercise Myocardial Perfusion SPECT in Patients Without Known Coronary Artery Disease | 583 |
ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article | 582 |
Adrenergic effects on the biology of the adult mammalian cardiocyte. | 580 |
Demonstration That C-Reactive Protein Decreases eNOS Expression and Bioactivity in Human Aortic Endothelial Cells | 579 |
Intravascular Ultrasound | 576 |
Accumulated Evidence on Fish Consumption and Coronary Heart Disease Mortality | 576 |
Estimation of Infarct Size in Man and its Relation to Prognosis | 575 |
Technique and Results of Linear Ablation at the Mitral Isthmus | 575 |
Restenosis after successful coronary angioplasty in patients with single-vessel disease. | 574 |
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension | 573 |
Fractional Flow Reserve to Determine the Appropriateness of Angioplasty in Moderate Coronary Stenosis | 573 |
Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With α
v
β
3
-Integrin–Targeted Nanoparticles | 573 |
Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. | 572 |
Healed Plaque Ruptures and Sudden Coronary Death | 571 |
Clinical and Pathophysiological Implications of a Bicuspid Aortic Valve | 569 |
In Vivo Magnetic Resonance Imaging of Mesenchymal Stem Cells in Myocardial Infarction | 569 |
Delayed Development of Ventricular Ectopic Rhythms following Experimental Coronary Occlusion | 568 |
Therapeutic Hypothermia After Cardiac Arrest | 568 |
QT interval prolongation as predictor of sudden death in patients with myocardial infarction. | 567 |
Selecting Patients With Atrial Fibrillation for Anticoagulation | 567 |
Cellular Basis for the Electrocardiographic J Wave | 565 |
Oxidative Stress and Cardiovascular Injury | 565 |
Sudden Death as a Complication of Anomalous Left Coronary Origin From the Anterior Sinus of Valsalva | 565 |
Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. | 564 |
The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris. | 563 |
Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure | 563 |
Reciprocal Association of C-Reactive Protein With Adiponectin in Blood Stream and Adipose Tissue | 563 |
Arterial Remodeling After Coronary Angioplasty | 562 |
Symptoms of Depression, Acute Myocardial Infarction, and Total Mortality in a Community Sample | 561 |
A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. | 561 |
Hormonal Changes and Catabolic/Anabolic Imbalance in Chronic Heart Failure and Their Importance for Cardiac Cachexia | 561 |
Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator–Activated Receptor-γ Activity | 560 |
Elevations of Inflammatory and Procoagulant Biomarkers in Elderly Persons With Renal Insufficiency | 560 |
Assessing Adiposity | 560 |
Inhalation of Fine Particulate Air Pollution and Ozone Causes Acute Arterial Vasoconstriction in Healthy Adults | 559 |
Epidemiology of Hypertrophic Cardiomyopathy–Related Death | 557 |
Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy | 557 |
Low Heart Rate Variability in a 2-Minute Rhythm Strip Predicts Risk of Coronary Heart Disease and Mortality From Several Causes | 557 |
Effects of Lipid Lowering by Pravastatin on Progression and Regression of Coronary Artery Disease in Symptomatic Men With Normal to Moderately Elevated Serum Cholesterol Levels | 555 |
Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease. | 554 |
Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke | 554 |
Distribution of circumferential stress in ruptured and stable atherosclerotic lesions. A structural analysis with histopathological correlation. | 553 |
Human Aortic Valve Calcification Is Associated With an Osteoblast Phenotype | 553 |
Catheter Ablation of Paroxysmal Atrial Fibrillation Initiated by Non–Pulmonary Vein Ectopy | 552 |
Long QT Syndrome Patients With Mutations of the
SCN5A
and
HERG
Genes Have Differential Responses to Na
+
| 552 |
Cardiovascular Complications of Cancer Therapy | 551 |
Quantification of Macrophage Content in Atherosclerotic Plaques by Optical Coherence Tomography | 551 |
Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs. | 550 |
Stable Microreentrant Sources as a Mechanism of Atrial Fibrillation in the Isolated Sheep Heart | 550 |
Advanced Coronary and Carotid Arteriopathy in Young Adults With Childhood-Onset Chronic Renal Failure | 550 |
Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. | 550 |
Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique. | 550 |
Dual Antiplatelet Therapy With Clopidogrel and Aspirin in Symptomatic Carotid Stenosis Evaluated Using Doppler Embolic Signal Detection | 550 |
Efficacy and Safety of Milrinone in Preventing Low Cardiac Output Syndrome in Infants and Children After Corrective Surgery for Congenital Heart Disease | 550 |
Recurrent sustained ventricular tachycardia. 1. Mechanisms. | 548 |
Ethnic Differences in Coronary Calcification | 548 |
Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitativ | 548 |
Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. | 548 |
Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. | 548 |
Acute Hyperglycemia Attenuates Endothelium-Dependent Vasodilation in Humans In Vivo | 546 |
Effectiveness and Limitations of β-Blocker Therapy in Congenital Long-QT Syndrome | 545 |
Chronic Heart Failure in the United States | 544 |
Estimating Effectiveness of Cardiac Arrest Interventions | 544 |
Plasma Concentrations and Genetic Variation of Matrix Metalloproteinase 9 and Prognosis of Patients With Cardiovascular Disease | 544 |
T
−786
→C Mutation in the 5′-Flanking Region of the Endothelial Nitric Oxide Synthase Gene Is Associated With Coronary Spasm | 544 |
Pathophysiologically Relevant Concentrations of Tumor Necrosis Factor-α Promote Progressive Left Ventricular Dysfunction and Remodeling in Rats | 544 |
Obesity, Insulin Resistance, Diabetes, and Cardiovascular Risk in Children | 544 |
ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction—2002: Summary Article | 544 |
Diagnostic efficiency of troponin T measurements in acute myocardial infarction. | 543 |
National Study of Physician Awareness and Adherence to Cardiovascular Disease Prevention Guidelines | 543 |
Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography. A comparison of cineangiographic and radionuclide techniques. | 543 |
Endothelial Dysfunction in Pulmonary Hypertension | 542 |
Intracoronary Stenting and Angiographic Results | 542 |
Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. | 542 |
Mechanisms and Models in Heart Failure | 541 |
Ischemic Stroke Subtype Incidence Among Whites, Blacks, and Hispanics | 541 |
Endothelial Function | 540 |
Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. | 540 |
Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens. | 540 |
Evidence for Possible Involvement of 5-HT
2B
Receptors in the Cardiac Valvulopathy Associated With Fenfluramine and Other Serotonergic Medications | 540 |